Spritzer Bhd (7103)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 3.580 |
|---|---|
| 52-week range | 2.330 – 3.900 |
| Return, 1 month / 3 months | −5.0% / +23.4% |
| Return, 1 year / 3 years | +31.3% / +396.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 52 |
| Volatility (1 year) | 35.0% |
| Worst drawdown (1 year) | -23.7% |
| Average daily value traded | 2.51M MYR |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Spritzer Bhd is a Malaysian bottled water company based in Perak. It produces natural mineral water and bottled drinking water under the Spritzer brand, along with carbonated and flavoured drinks. Its customers are everyday consumers and retailers across Malaysia, who buy its bottled water for home, office and on-the-go drinking. The company also makes water dispensers and related products for households and businesses.
On this site Spritzer Bhd appears as a stock on the Bursa Malaysia (Malaysia), code 7103, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Spritzer Bhd (7103) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 3.580 on 27 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 60 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.3% and over the last three months it rose 23.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 21.4% | ||
| From 52-week high | -7.0% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.4% | ||
| 6-month return | 36.2% | ||
| 12-month return, skipping the last month | 38.3% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.7% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 2.51M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | −5.0% |
| 3 months | +23.4% |
| 6 months | +36.2% |
| 1 year | +31.3% |
| 3 years | +396.4% |
| 5 years | +502.8% |
Signals
| 50-day / 200-day average | 3.586 / 2.949 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.099 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jun 2026 | MYR 0.0500 |
| 5 Jun 2025 | MYR 0.0400 |
| 6 Jun 2024 | MYR 0.0550 |
| 8 Jun 2023 | MYR 0.0625 |
| 8 Jun 2022 | MYR 0.0450 |
| 3 Jun 2021 | MYR 0.0450 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.